Vigil Neuroscience
VIGL
VIGL was delisted on the 4th of August, 2025.
51 hedge funds and large institutions have $38.4M invested in Vigil Neuroscience in 2024 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 19 increasing their positions, 11 reducing their positions, and 11 closing their positions.
73% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 11
9% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 11
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
2% less funds holding
Funds holding: 52 → 51 (-1)
14.61% less ownership
Funds ownership: 69.92% → 55.32% (-15%)
59% less capital invested
Capital invested by funds: $94.5M → $38.4M (-$56M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IC
Ikarian Capital
Dallas,
Texas
|
+$1.48M |
| 2 |
WP
Woodline Partners
San Francisco,
California
|
+$1.02M |
| 3 |
William Blair & Company
Chicago,
Illinois
|
+$956K |
| 4 |
Renaissance Technologies
New York
|
+$949K |
| 5 |
Aberdeen Group
Edinburgh,
United Kingdom
|
+$867K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$5.28M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$3.99M |
| 3 |
SC
Stempoint Capital
New York
|
-$2.53M |
| 4 |
O
OrbiMed
New York
|
-$1.53M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$429K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
UBS Group
Zurich,
Switzerland
| $2 | -$833 | -282 | -100% |
|
|
DTC
52
Deep Track Capital
Greenwich,
Connecticut
| – | -$5.28M | -1,553,996 | Closed |
|
|
SC
53
Stempoint Capital
New York
| – | -$2.53M | -743,719 | Closed |
|
|
O
54
OrbiMed
New York
| – | -$1.53M | -448,891 | Closed |
|
55
Walleye Capital
New York
| – | -$407K | -119,792 | Closed |
|
|
SPA
56
Sherbrooke Park Advisers
White Plains,
New York
| – | -$89.5K | -26,329 | Closed |
|
|
JF
57
Jump Financial
Chicago,
Illinois
| – | -$34K | -10,000 | Closed |
|
|
GAM
58
Gotham Asset Management
New York
| – | -$207K | -5,933 | Closed |
|
|
CFM
59
Catalyst Funds Management
Sydney NSW,
Australia
| – | -$13.9K | -4,100 | Closed |
|
60
Fidelity Investments
Boston,
Massachusetts
| – | -$7.09K | -2,086 | Closed |
|
61
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$2K | -471 | Closed |
|
62
Nisa Investment Advisors
St. Louis,
Missouri
| – | -$153 | -45 | Closed |
|
VIGL Hedge Fund Activity: Q4 2024 in Review
51 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Vigil Neuroscience (VIGL) for Q4 2024, worth a combined $38.4M — down 59% from $94.5M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new VIGL positions and 11 closed out — a net gain of 1 holder — while 19 added to existing stakes and 11 trimmed.
The largest buyer was Ikarian Capital, opening a new position worth an estimated $1.48M. The largest seller was Deep Track Capital, exiting entirely with an estimated $5.28M sold.
- 51 institutional investors held Vigil Neuroscience (VIGL) as of Q4 2024, down from 52 in Q3 2024.
- Funds reported $38.4M of Vigil Neuroscience stock for Q4 2024, down 59% quarter-over-quarter.
- 12 funds opened new Vigil Neuroscience positions in Q4 2024 and 11 closed out, a net change of +1 holder.
- The largest Vigil Neuroscience buyer in Q4 2024 was Ikarian Capital, an estimated $1.48M added.
- The largest Vigil Neuroscience seller in Q4 2024 was Deep Track Capital, an estimated $5.28M sold.
Based on aggregated 13F filings for Q4 2024.